Literature DB >> 23750731

The burden and impact of severe and long-term sequelae of meningococcal disease.

Andrew Vyse1, Andrea Anonychuk, Anne Jäkel, Heather Wieffer, Simon Nadel.   

Abstract

This review describes current knowledge on the severity and long-term sequelae of meningococcal disease (MD) specifically. The literature databases Medline and Embase were used by combining search terms for MD and Neisseria meningitidis with terms for severity, mortality and sequelae. Case fatality for sufferers of MD remains high, typically 5-10%, despite the best medical care. Long-term sequelae in survivors may include physical, neurological, cognitive, behavioral and psychological consequences, such as hearing loss, amputations, skin scarring and neurodevelopmental deficits. A significantly lower quality of life is seen in survivors of MD compared with unaffected controls, with detrimental effects of childhood MD continuing into adulthood. MD carries a substantial risk of long-term sequelae and mortality. This should be recognized by physicians treating patients with this disease and lends support for the implementation of preventative measures such as vaccination.

Entities:  

Mesh:

Year:  2013        PMID: 23750731     DOI: 10.1586/eri.13.42

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  13 in total

1.  Costs of Invasive Meningococcal Disease: A Global Systematic Review.

Authors:  Bing Wang; Renee Santoreneos; Hossein Afzali; Lynne Giles; Helen Marshall
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

2.  Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.

Authors:  Michael Bröker; Suzana Bukovski; Davor Culic; Susanne Jacobsson; Maria Koliou; Markku Kuusi; Maria João Simões; Anna Skoczynska; Maija Toropainen; Muhamed-Keir Taha; Georgina Tzanakaki
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

3.  Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.

Authors:  Muhamed-Kheir Taha; Catherine Weil-Olivier; Stéphane Bouée; Corinne Emery; Gaëlle Nachbaur; Céline Pribil; Véronique Loncle-Provot
Journal:  Hum Vaccin Immunother       Date:  2021-01-15       Impact factor: 3.452

4.  Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility.

Authors:  Joseph J E Caesar; Hayley Lavender; Philip N Ward; Rachel M Exley; Jack Eaton; Emily Chittock; Talat H Malik; Elena Goiecoechea De Jorge; Matthew C Pickering; Christoph M Tang; Susan M Lea
Journal:  Elife       Date:  2014-12-23       Impact factor: 8.140

Review 5.  Routinely vaccinating adolescents against meningococcus: targeting transmission & disease.

Authors:  Volker Vetter; Roger Baxter; Gülhan Denizer; Marco A P Sáfadi; Sven-Arne Silfverdal; Andrew Vyse; Ray Borrow
Journal:  Expert Rev Vaccines       Date:  2016-03-04       Impact factor: 5.217

6.  A Survey of Serum Bactericidal Antibodies against Neisseria meningitidis Serogroups A, C, W and Y in Adolescents and Adults in the Republic of Korea.

Authors:  Jin-Han Kang; Yan Miao; SooYoung Lee; Jong-Hyun Kim; Kyung-Yil Lee; Sang Hyuk Ma; Dae Sun Jo; HyoYoung Song; Mendel Haag
Journal:  Infect Chemother       Date:  2016-03-31

Review 7.  N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network.

Authors:  Elena Gianchecchi; Alessandro Torelli; Giulia Piccini; Simona Piccirella; Emanuele Montomoli
Journal:  Vaccines (Basel)       Date:  2016-05-27

8.  A qualitative feasibility study to inform a randomised controlled trial of fluid bolus therapy in septic shock.

Authors:  Caitlin B O'Hara; Ruth R Canter; Paul R Mouncey; Anjali Carter; Nicola Jones; Simon Nadel; Mark J Peters; Mark D Lyttle; David A Harrison; Kathryn M Rowan; David Inwald; Kerry Woolfall
Journal:  Arch Dis Child       Date:  2017-08-28       Impact factor: 3.791

9.  The spread of chloramphenicol-resistant Neisseria meningitidis in Southeast Asia.

Authors:  Elizabeth M Batty; Tomas-Paul Cusack; Janjira Thaipadungpanit; Wanitda Watthanaworawit; Verena Carrara; Somsavanh Sihalath; Jill Hopkins; Sona Soeng; Clare Ling; Paul Turner; David A B Dance
Journal:  Int J Infect Dis       Date:  2020-04-08       Impact factor: 3.623

10.  Economic evaluation of meningococcal vaccines: considerations for the future.

Authors:  Hannah Christensen; Hareth Al-Janabi; Pierre Levy; Maarten J Postma; David E Bloom; Paolo Landa; Oliver Damm; David M Salisbury; Javier Diez-Domingo; Adrian K Towse; Paula K Lorgelly; Koonal K Shah; Karla Hernandez-Villafuerte; Vinny Smith; Linda Glennie; Claire Wright; Laura York; Raymond Farkouh
Journal:  Eur J Health Econ       Date:  2019-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.